GALAPAGOS EXCEEDS 92% ACCEPTANCE OF BIOFOCUS SHARES AND CLOSES OFFER

Galapagos NV (Euronext Brussels: GLPG; Euronext Amsterdam: GLPGA, London AiM: GLPG) announced today that with over 92% of the BioFocus plc shares submitted for exchange into Galapagos shares, the acquisition of BioFocus is completed and the remaining shares in BioFocus will be acquired compulsorily. On 21 September 2005, Galapagos made a recommended all share offer to acquire the entire issued and to be issued ordinary share capital of BioFocus plc. On 13 October 2005 the offer was declared unconditional as to acceptances and on 17 October the offer became wholly unconditional.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/741ba222a71167264837bfca574e0806.html)